Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Breast Cancer Res Treat. 2012 Dec 22;137(2):493–502. doi: 10.1007/s10549-012-2385-x

Figure 3.

Figure 3

Oxidative DNA damage in breast cancer survivors (BCS) as measured by Comet assay of peripheral lymphocytes vs. mean gray matter density (GMD) of clusters in which BCS showed relatively decreased GMD compared to healthy controls (HC)